Additionally, NT‐proBNP is less useful in HFpEF compared with HFrEF because clinical features of HFpEF, such as atrial fibrillation, obesity, and renal impairment significantly impact NT‐proBNP. This evidence concerns the gene NPPB and atrial fibrillation.